Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-11

Clinical Trial Update: Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the pharmacokinetic interaction between apixaban and the immunosuppressants cyclosporine and tacrolimus to assess potential changes…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CYCLOSPORINE (cyclosporine)
  • Eliquis (apixaban)
  • Prograf (Tacrolimus)

Snippet

Sponsor: Thomas Jefferson University | Conditions: Venous Thromboembolism, Pharmacokinetics | Phase 1 | Status: COMPLETED